MSU Researchers Call for Better Warning Labels on Prescription Medications
Many adverse reactions to prescription medications could be avoided if warning labels were more effective, according to a Michigan State University study.
Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!
The researchers discovered that only 50 percent of study participants looked directly at the warning labels, and 22 percent did not look at any. When patients are handed a new prescription, few read the critical warning labels such as "do not consume alcohol while taking this medication" or "for external use only." Using eye-tracking technology, MSU researchers found that one source of the labels' ineffectiveness is an inability to capture patients' attention.
The researchers' initial recommendations include moving all warnings from the colored stickers to the main white label, which 100 percent of the participants read, or repositioning the warnings so that they can be seen more easily.
More Articles on Medication Safety:
FDA Commissioner: Patient Safety Must Be Prioritized Over Job Creation
© Copyright ASC COMMUNICATIONS 2012. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
To receive the free Becker's Operating Room Clinical Quality & Infection Control
E-Weekly, which focuses on clinical quality, infection control, patient safety and accreditation, click here.
Latest Articles
- Senate Introduces Companion Medicare RAC Reform Bill
- Drs. Brian Cole, Anthony Romeo of Midwest Orthopaedics at Rush Among Top Orthopedic Surgeons Contributing to Orthopedic Literature
- Spinal Elements Upgrades to 40,000-Square-Foot Headquarters
- UnitedHealth, Aetna, Cigna to Sit Out of California's Health Insurance Exchange
- Rhode Island Nixes "Confidential" Prices Between Payors, Providers




